Effect of Drug-Eluting Stents on Frequency of Repeat Revascularization in Patients With Unstable Angina Pectoris or Non-ST-Elevation Myocardial Infarction
Authors:
- Rebecca TorgusonRTRebecca Torguson
- Asmir I. SyedASAsmir I. Syed
- Itsik Ben-DorIBItsik Ben-Dor
- Sara D. CollinsSCSara D. Collins
- Gabriel MaluendaGMGabriel Maluenda
- Mickey ScheinowitzMSMickey Scheinowitz
- Kimberly KaneshigeKKKimberly Kaneshige
- Zhenyi XueZXZhenyi Xue
- Gilles LemesleGLGilles Lemesle
- Lowell F. SatlerLSLowell F. Satler
- William O. SuddathWSWilliam O. Suddath
- 1 December 2009
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 104 (12) , 1654-1659
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Temporal Changes in Coronary Revascularization Procedures, Outcomes, and Costs in the Bare-Metal Stent and Drug-Eluting Stent ErasCirculation, 2009
- Primary Percutaneous Coronary Intervention for Acute Myocardial InfarctionCirculation: Cardiovascular Interventions, 2008
- Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarctionEuropean Heart Journal, 2007
- Clinical End Points in Coronary Stent TrialsCirculation, 2007
- Prevention of Premature Discontinuation of Dual Antiplatelet Therapy in Patients With Coronary Artery StentsCirculation, 2007
- Late Clinical Events After Clopidogrel Discontinuation May Limit the Benefit of Drug-Eluting StentsJACC, 2006
- Heart Disease and Stroke Statistics—2006 UpdateCirculation, 2006
- From Vulnerable Plaque to Vulnerable PatientCirculation, 2003
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003
- Angiographic progression of coronary artery disease and the development of myocardial infarctionJACC, 1988